Export 2761 results:
Author Title [ Type(Asc)] Year
Journal Article
S. DM, “Trend in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)”, 1998.
A. Veitz-Keenan, Barna, J. Ann, Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., “Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study.”, J Am Dent Assoc, vol. 144, no. 5, pp. 495-506, 2013.
A. Veitz-Keenan, Barna, J. A., Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., “Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study”, J Am Dent Assoc, vol. 144, pp. 495-506, 2013.
O. Gasser, Bihl, F., Sanghavi, S., Rinaldo, C., Rowe, D., Hess, C., Stablein, D., Roland, M., Stock, P., and Brander, C., “Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.”, Am J Transplant, vol. 9, no. 4, pp. 794-803, 2009.
O. Gasser, Bihl, F., Sanghavi, S., Rinaldo, C., Rowe, D., Hess, C., Stablein, D., Roland, M., Stock, P., and Brander, C., “Treatment-Dependent Loss of Polyfunctional Cd8+ T-Cell Responses in HIV-Infected Kidney Transplant Recipients Is Associated with Herpesvirus Reactivation”, Am J Transplant, vol. 9, pp. 794-803, 2009.
K. A. Holtz, Szefer, E., Noonan, V. K., Kwon, B. K., and Mills, P. B., “Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study.”, Spinal Cord, vol. 56, no. 12, pp. 1176-1183, 2018.
V. DA, “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute; 5-year follow-up report,”, J Clin Oncol, vol. 15, 1997.
J. M. Sorensen, Vena, D. A., Fallavollita, A., Chun, H. G., and Cheson, B. D., “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.”, J Clin Oncol, vol. 15, no. 2, pp. 458-65, 1997.
E. Atallah, Bylow, K., Troy, J., and W, S., “Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)”, Curr Hematol Malig Rep, vol. 9, pp. 57-65, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., “Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).”, Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.”, Proc Natl Acad Sci U S A, vol. 96, no. 13, pp. 7462-6, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial”, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
J. Smith, Thompson, D., Whitcup, S., Suhler, E., Clarke, G., Robinson, M., and Baron, K., “The treatment of JRA-associated uveitis with Etanercept”, 2002.
B. D. Cheson, Sorensen, J. M., Vena, D. A., Montello, M. J., Barrett, J. A., Damasio, E., Tallman, M., Annino, L., Connors, J., Coiffier, B., and Lauria, F., “Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.”, J Clin Oncol, vol. 16, no. 9, pp. 3007-15, 1998.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., and Chew, E. Y., “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., “Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
G. Gensler, Clemons, T. E., Domalpally, A., Danis, R. P., Blodi, B., Wells, J., Rauser, M., Hoskins, J., G Hubbard, B., Elman, M. J., Fish, G. E., Brucker, A., Margherio, A., and Chew, E. Y., “Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”, Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
W. T. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C. B., Cukras, C., Chew, E. Y., Sadda, S. V. R., and Ferris, F. L., “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., “Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial”, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
J. M. Palefsky, Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Gomez, M. Tirado, Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., Logan, J., Aboulafia, D. M., Schouten, J. T., de la Ossa, J., Levine, R., Korman, J. D., Hagensee, M., Atkinson, T. M., Einstein, M. H., Cracchiolo, B. M., Wiley, D., Ellsworth, G. B., Brickman, C., and J Berry-Lawhorn, M., “Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.”, N Engl J Med, vol. 386, no. 24, pp. 2273-2282, 2022.
J. Alexander, Metze, T., Goodman, H., McIntosh, M., Zeng, L., Cardi, M., Austin, J., Goel, S., Safdar, S., Greenburg, N., and Woodle, E., “Transplant Success and Immunodulating Diets”, 2003.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., “Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial”, JAMA, vol. 311, pp. 62-73, 2014.
J. B. Goll, Li, S., Edwards, J. L., Bosinger, S. E., Jensen, T. L., Wang, Y., Hooper, W. F., Gelber, C. E., Sanders, K. L., Anderson, E. J., Rouphael, N., Natrajan, M. S., Johnson, R. A., Sanz, P., Hoft, D., and Mulligan, M. J., “Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
R. Kosoy, Agashe, C., Grishin, A., Leung, D. Y., Wood, R. A., Sicherer, S. H., Jones, S. M., A Burks, W., Davidson, W. F., Lindblad, R. W., Dawson, P., Merad, M., Kidd, B. A., Dudley, J. T., Sampson, H. A., and M Berin, C., “Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype.”, PLoS One, vol. 11, no. 10, p. e0163831, 2016.
E. Shemesh, Duncan, S., Anand, R., Shneider, B. L., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Annunziato, R. A., and Bucuvalas, J. C., “Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort.”, Liver Transpl, vol. 24, no. 1, pp. 80-88, 2018.